SCHEMBL31332118

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	AGTR2	P50052	10/20	0.71

▸	AGTR1	P30556	4/20	0.71

▸	NTSR1	P30989	2/20	0.59

▸	NTSR2	O95665	1/20	0.59

▸	REN	P00797	1/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31332203	0.98	AGTR2 (0.75)	AGTR2AGTR1
SCHEMBL28485749	0.86	AGTR2 (0.94)	AGTR2AGTR1NTSR1NTSR2
Acetic Acid SCHEMBL21811310	0.85	AGTR2 (0.92)	AGTR2AGTR1NTSR1NTSR2
Angiotensin Ii SCHEMBL29361852	0.84	AGTR2 (1.00)	AGTR2AGTR1
Angiotensin Ii SCHEMBL21811603	0.84	AGTR2 (1.00)	AGTR2AGTR1
Angiotensin Ii SCHEMBL1650427	0.84	AGTR2 (1.00)	AGTR2AGTR1
SCHEMBL29394721	0.84	AGTR2 (1.00)	AGTR2AGTR1
SCHEMBL30203194	0.84	AGTR2 (0.89)	AGTR2AGTR1REN
Angiotensin Amide SCHEMBL4448793	0.83	AGTR2 (0.63)	AGTR2AGTR1REN
Angiotensin Ii SCHEMBL31477824	0.83	AGTR2 (0.98)	AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	AGTR2 100/4885AGTR1 51/4885NTSR1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.